203 related articles for article (PubMed ID: 34918244)
1. Production of a Hepatitis E Vaccine Candidate Using the Pichia pastoris Expression System.
Gupta J; Kumar A; Surjit M
Methods Mol Biol; 2022; 2412():117-141. PubMed ID: 34918244
[TBL] [Abstract][Full Text] [Related]
2. Expression, Purification and Characterization of the Hepatitis E Virus Like-Particles in the
Gupta J; Kaul S; Srivastava A; Kaushik N; Ghosh S; Sharma C; Batra G; Banerjee M; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
Front Microbiol; 2020; 11():141. PubMed ID: 32117160
[TBL] [Abstract][Full Text] [Related]
3. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
Mazalovska M; Kouokam JC
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
[TBL] [Abstract][Full Text] [Related]
4. Production in Pichia pastoris and characterization of genetic engineered chimeric HBV/HEV virus-like particles.
Li HZ; Gang HY; Sun QM; Liu X; Ma YB; Sun MS; Dai CB
Chin Med Sci J; 2004 Jun; 19(2):78-83. PubMed ID: 15250239
[TBL] [Abstract][Full Text] [Related]
5. Production of capsid proteins of rat hepatitis E virus in Escherichia coli and characterization of self-assembled virus-like particles.
Kobayashi T; Takahashi M; Ohta S; Nagashima S; Primadharsini PP; Mulyanto ; Kunita S; Murata K; Okamoto H
Virus Res; 2021 Sep; 302():198483. PubMed ID: 34146611
[TBL] [Abstract][Full Text] [Related]
6. [Antigencity identification of recombinant hepatitis E virus ORF2 protein expressed in Pichia pastoris].
Tong YP; Bi SL; Lu J; Jiang YZ; Zhan MY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):258-61. PubMed ID: 15340572
[TBL] [Abstract][Full Text] [Related]
7. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
[TBL] [Abstract][Full Text] [Related]
8. Immunization with recombinant ORF2 p551 protein protects common marmosets (Callithrix jacchus) against homologous and heterologous hepatitis E virus challenge.
Gordeychuk I; Kyuregyan K; Kondrashova A; Bayurova E; Gulyaev S; Gulyaeva T; Potemkin I; Karlsen A; Isaeva O; Belyakova A; Lyashenko A; Sorokin A; Chumakov A; Morozov I; Isaguliants M; Ishmukhametov A; Mikhailov M
Vaccine; 2022 Jan; 40(1):89-99. PubMed ID: 34836660
[TBL] [Abstract][Full Text] [Related]
9. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
[TBL] [Abstract][Full Text] [Related]
10. Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus.
Li TC; Takeda N; Miyamura T; Matsuura Y; Wang JC; Engvall H; Hammar L; Xing L; Cheng RH
J Virol; 2005 Oct; 79(20):12999-3006. PubMed ID: 16189002
[TBL] [Abstract][Full Text] [Related]
11. Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
Zheng M; Jiang J; Zhang X; Wang N; Wang K; Li Q; Li T; Lin Q; Wang Y; Yu H; Gu Y; Zhang J; Li S; Xia N
Vaccine; 2018 Apr; 36(16):2104-2111. PubMed ID: 29544686
[TBL] [Abstract][Full Text] [Related]
12. [Expression,Purification,Structure Determination and Immunogenicity Assay of Hepatitis E Virus Capsid Protein p495 Derived from Baculovirus-based Insect Cell].
Lin Q; Jiang J; Li T; Zhang Y; Zhang Z; Zheng M; Wang K; Zheng Q; Yu H; Gu Y; Xia N; Li S
Bing Du Xue Bao; 2016 May; 32(3):342-8. PubMed ID: 29963821
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.
Panda SK; Kapur N; Paliwal D; Durgapal H
J Nanobiotechnology; 2015 Jun; 13():44. PubMed ID: 26104584
[TBL] [Abstract][Full Text] [Related]
14. A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity.
Chen Z; Guo S; Li G; Ying D; Wen G; Fang M; Wang Y; Tang Z; Zheng Z; Xia N
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298677
[TBL] [Abstract][Full Text] [Related]
15. Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes.
Wei M; Zhang X; Yu H; Tang ZM; Wang K; Li Z; Zheng Z; Li S; Zhang J; Xia N; Zhao Q
Vaccine; 2014 May; 32(24):2859-65. PubMed ID: 24662711
[TBL] [Abstract][Full Text] [Related]
16. Expression and immunogenicity of hepatitis E virus-like particles based on recombinant truncated ORF2 capsid protein.
Cao YF; Zhou YF; Zhao DY; Chang JL; Tang JG; Chang DY; Zhang XM; Wang XP
Protein Expr Purif; 2023 Mar; 203():106214. PubMed ID: 36526214
[TBL] [Abstract][Full Text] [Related]
17. [Immunogenicity of recombinant HEV ORF2 protein expressed in pichia pastoris].
Tong Y; Zhan M; Lu J; Bai Y; Bi S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):23-6. PubMed ID: 11986739
[TBL] [Abstract][Full Text] [Related]
18. Expression and self-assembly of empty virus-like particles of hepatitis E virus.
Li TC; Yamakawa Y; Suzuki K; Tatsumi M; Razak MA; Uchida T; Takeda N; Miyamura T
J Virol; 1997 Oct; 71(10):7207-13. PubMed ID: 9311793
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.
Montpellier C; Wychowski C; Sayed IM; Meunier JC; Saliou JM; Ankavay M; Bull A; Pillez A; Abravanel F; Helle F; Brochot E; Drobecq H; Farhat R; Aliouat-Denis CM; Haddad JG; Izopet J; Meuleman P; Goffard A; Dubuisson J; Cocquerel L
Gastroenterology; 2018 Jan; 154(1):211-223.e8. PubMed ID: 28958858
[TBL] [Abstract][Full Text] [Related]
20. Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®).
Zhang X; Wei M; Pan H; Lin Z; Wang K; Weng Z; Zhu Y; Xin L; Zhang J; Li S; Xia N; Zhao Q
Vaccine; 2014 Jul; 32(32):4039-50. PubMed ID: 24892250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
